Corporate Structure We were incorporated as Cetrone Energy Company on January 28, 2008 in the State of Nevada. From inception until we completed our reverse acquisition of Fresh Start Private, Inc. (“FSP”), the principal business of the Company originally was to develop “green” renewable fuel sources for agricultural operations, specifically biodiesel. On July 26, 2010, we filed an amendment to our articles of incorporation changing our name to Fresh Start Private Management, Inc. During that time, we had no revenue and our operations were limited to capital formation, organization, and development of our business plan and target customer market. As a result of the reverse acquisition of FSP, on October 31, 2011, we ceased our prior operations and we are now a holding company and our wholly owned subsidiary engages in alcoholism and opioid addiction treatment through our BioCorRx® Recovery Program and related products.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 948K | - | - | - | - | - |
| Net Income | -5.1M | -5.1M | -3.8M | -4.4M | -5.2M | -3.5M |
| EPS | $-0.36 | $-0.32 | $-0.23 | $-0.50 | $-0.81 | $-0.65 |
| Free Cash Flow | 0 | -1.1M | -1.9M | -2.0M | -3.6M | -2.2M |
| ROIC | -56.9% | -1048.5% | -769.5% | -484.1% | -530.9% | -324.0% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | -0.24 | -0.14 | -0.11 | -0.11 | -0.04 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -5.4M | -5.1M | -3.8M | -4.7M | -5.5M | -7.5M |
| Operating Margin | -571.7% | - | - | - | - | - |
| ROE | 0.0% | - | - | - | - | - |
| Shares Outstanding | 24M | 16M | 16M | 9M | 6M | 5M |
BioCorRx Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
BioCorRx Inc. (BICX) has a market capitalization of $6M. It is classified as a small-cap stock.
BioCorRx Inc. (BICX) does not currently pay a regular dividend.
BioCorRx Inc. (BICX) operates in the Services-Specialty Outpatient Facilities, Nec industry, within the Healthcare sector.
BioCorRx Inc. (BICX) generated $-1 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
BioCorRx Inc. (BICX) reported earnings per share (EPS) of $-0.32 in its most recent fiscal year.
The Ledger Terminal provides 15 years of financial data for BioCorRx Inc. (BICX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
BioCorRx Inc. (BICX) has a book value per share of $-0.75, based on its most recent annual SEC filing.